Skip to main content

Table 5 Efficacy outcomes on day 28 and 42 in the SCD and HbAA groups

From: A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

Day 28

SCD

HbAA

 

Uncorrected

PCR-corrected

Uncorrected

PCR-corrected

ACPR

58

59

57

57

ETF

0

0

0

0

LCF

0

0

0

0

LPF

1

0

0

0

Day 42

SCD

 

HbAA

 

ACPR

55

56

53

54

ETF

0

0

0

0

LCF

0

0

0

0

LPF

2

1

2

1

  1. ACPR = adequate clinical and parasitological response, ETF = early treatment failure, LCF = late clinical failure, LPF = late parasitological failure, SCD = sickle cell disease, HbAA = non-SCD.
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us